Trials / Completed
CompletedNCT01419145
A Feasibility Study of Multimodal Exercise/Nutrition/Anti-inflammatory Treatment for Cachexia - the Pre-MENAC Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 46 (actual)
- Sponsor
- Norwegian University of Science and Technology · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
A multicentre, open, randomized phase II study comparing a multimodal intervention (oral nutritional supplements, celecoxib and physical exercise) for cachexia versus standard cancer care.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Multimodal intervention | Nutritional supplements aimed at optimal energy balance and protein intake (2 cartons of ProSure per day), nutritional advice, home-based self-assisted exercise program and anti-inflammatory treatment (300 mg celecoxib) for 6 weeks. The aerobic exercise program is performed as self-administered daily walking sessions, aiming for a minimum of two sessions 30 minutes on a weekly basis. Other aerobic activities could be used instead of walking. The resistance exercise program should be performed 3 times weekly and lasts about 20 minutes. The program is targeting major muscle groups in the upper body and legs with use of weights. The intensity of the exercise and performance of the exercises are adapted to the individual patient's disease burden and physical performance. |
| OTHER | Standard care | Standard cancer care |
Timeline
- Start date
- 2011-10-01
- Primary completion
- 2014-08-01
- Completion
- 2014-11-01
- First posted
- 2011-08-17
- Last updated
- 2017-06-16
Locations
3 sites across 2 countries: Norway, United Kingdom
Source: ClinicalTrials.gov record NCT01419145. Inclusion in this directory is not an endorsement.